GENETIC TESTING FOR THE UGT1A1*28 VARIANT TO PREDICT TOXICITY IN PATIENTS TREATED WITH IRINOTECAN BASED THERAPY Irinotecan (CPT-11) is a topoisomerase I inhibitor primarily used for the treatment of metastatic colorectal cancer in combination with 5-fluorouracil and/or leucovorin and in combination with tyrosine kinase inhibitors (e.g. cetuximab). Up to 36% of patients treated with irinotecan […]
ViewEXCELLING IN SCIENCE & SERVICE